Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Larimar Therapeutics Inc. sell ReynadJ

Start price
€12.10
18.02.24 / 0%
Target price
-
18.02.25
Performance (%)
-74.55%
End price
€3.08
19.02.25
Summary
This prediction ended on 19.02.25 with a price of €3.08. The SELL prediction by ReynadJ for Larimar Therapeutics Inc. performed very well with a performance of -74.55%. This prediction was marked as speculative and is excluded from ReynadJ's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
Larimar Therapeutics Inc. -7.647% -7.647% -30.531%
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

According to ReynadJ what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment
Bad rating
High valuation
Low dividend yield expected
negative Cash Flow expected
Little Investments for future growth

Comments by ReynadJ for this prediction

In the thread Zafgen Inc. diskutieren

Sell Larimar Therapeutics Inc.

In the thread Trading Zafgen Inc.
Prediction Sell
Perf. (%) -74.55%
Target price
Change
Ends at 18.02.25

Die von ReynadJ gewählte maximale Laufzeit wurde überschritten